1. Lenalidomide following fludarabine and rituximab in previously untreated CLL
   Chaitra Ujjani et al, 2015, Hematology and Leukemia CrossRef
2. ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma
   Mengzhou Cao et al, 2023, Frontiers in Immunology CrossRef